FIELD: medical engineering.
SUBSTANCE: device has substrate having polymeric working layer on it, produced from copolymer based on methacrylic acid derivatives with biological macromolecules (probes) immobilized thereon. The substrate is manufactured from activated or not activated glass, metal or polymer material. The working layer has macroporous monolithic copolymer glycidyl methacrylate and ethylene glycol methacrylate taken in (50:70)-(50:30) proportions by mass with affine biological probes immobilized thereon. Probe-copolymer proportion is 2-10 mg/g of copolymer, for protein, 1-20 mg/g of copolymer for peptide and for oligonucleotide, nucleic acid - 0.5-3 mg/g of copolymer, pore radius of 0.4-1.5 mcm, it has thickness of 50-700 microns and is manufactured as continuous or discrete microcellular layer. The method for manufacturing biochip involves preparing substrate, producing working layer by monomer copolymerization on methacrylic acid derivatives base, immobilizing biological macromolecules - probes on forming copolymer, washing, drying the received biochip. Radical copolymerization of glycidyl methacrylate and ethylene glycol methacrylate taken in (50:70)-(50:30) proportions by mass is carried out for producing working layer with photo-or thermal initiation in poregenic solvent medium being applied. Proportion of the sum of monomer volumes to solvent volume being equal to 6:9, initiator concentration in reactionary medium being equal to 0.2-1.0% by weight, given reaction mixture is placed on substrate as continuous or discrete layer. Macroporous monolithic continuous or discrete microcellular layer is formed as a result of copolymerization on the substrate. Then, covalent immobilization of biological macromolecules is carried out in the layer pores or their direct synthesis on formed copolymer with its native or modified epoxy groups being used. Biological affine probe is produced. The probe is introduced into copolymer in quantity of 2-10 mg/g of copolymer for fiber, for peptide - 1-20 mg/g of copolymer and for oligonucleotide or nucleic acid - 0.5-3 mg/g of copolymer.
EFFECT: manufacturing reusable biochip with predetermined controllable and reproduced quality.
17 cl
Title | Year | Author | Number |
---|---|---|---|
MATERIAL FOR MAKING BIOCHIP | 2010 |
|
RU2456314C2 |
METHOD OF OBTAINING MONOLITHIC MACROPOROUS POLYMER MATERIAL | 2009 |
|
RU2401693C1 |
COMPOSITION FOR IMMOBILIZATION OF BIOLOGICAL MACROMOLECULE IN HYDROGEL, METHOD FOR PREPARING COMPOSITION, BIOCHIP, METHOD FOR CARRYING OUT POLYMERASE CHAIN REACTION (PCR) ON BIOCHIP | 2001 |
|
RU2206575C2 |
METHOD AND BIOCHIP FOR RECORDING MACROMOLECULES IN CARRYING OUT PROTEOMIC RESEARCH | 2004 |
|
RU2283496C2 |
USING UNMODIFIED POLYMERIC MATERIALS FOR PREPARING BIOCHIP BACKING, BIOCHIP BASED ON THEREOF AND METHOD FOR ITS PREPARING, METHOD FOR IMMOBILIZATION OF HYDROGELS ON UNMODIFIED POLYMERIC MATERIALS | 2006 |
|
RU2309959C1 |
METHOD OF SPECIFIC MACROMOLECULES RECORD IN BIOLOGICAL SAMPLE AND RELATED DEVICE | 2006 |
|
RU2338199C2 |
NANODIAGNOSIS TEST-SYSTEM FOR DETECTING HEPATITIS B VIRUS | 2004 |
|
RU2315999C2 |
NANO-BIOCHIP USED FOR REGISTRATION OF PROTEINS AND ALBUMINOUS COMPLEXES, WAY OF ITS RECEPTION AND WAY OF REGISTRATION OF PROTEINS AND ALBUMINOUS COMPLEXES WITH USE OF CATHETER MICROSCOPY | 2007 |
|
RU2362169C2 |
METHOD OF CHROMATOGRAPHIC SEPARATION OF IONS | 0 |
|
SU1237231A1 |
BIOLOGICAL MICROCHIP FOR DETECTION OF TUMOR EXOSOMES IN SERUM OF HUMAN FOR DIAGNOSING COLORECTAL CANCER | 2016 |
|
RU2682721C2 |
Authors
Dates
2007-05-10—Published
2005-05-03—Filed